| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An Economic Justification for Open Access to Essential Medicine Patents in Developing Countries
|
Flynn, Sean
|
|
2009
|
37 |
2 |
p. 184-208
|
artikel
|
| 2 |
Calendar of Events
|
|
|
2009
|
37 |
2 |
p. 389
|
artikel
|
| 3 |
Collaborated Death: An Exploration of the Swiss Model of Assisted Suicide for Its Potential to Enhance Oversight and Demedicalize the Dying Process
|
Ziegler, Stephen J.
|
|
2009
|
37 |
2 |
p. 318-330
|
artikel
|
| 4 |
Commentary: Innovation Policy for a New Era
|
Kapczynski, Amy
|
|
2009
|
37 |
2 |
p. 264-268
|
artikel
|
| 5 |
Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options
|
Reichman, Jerome H.
|
|
2009
|
37 |
2 |
p. 247-263
|
artikel
|
| 6 |
Compulsory Licensing in Canada and Thailand: Comparing Regimes to Ensure Legitimate Use of the WTO Rules
|
Lybecker, Kristina M.
|
|
2009
|
37 |
2 |
p. 222-239
|
artikel
|
| 7 |
Currents in Contemporary Ethics Direct-to-Consumer Genetic Testing: Is it the Practice of Medicine?
|
Marietta, Cynthia
|
|
2009
|
37 |
2 |
p. 369-374
|
artikel
|
| 8 |
Developing Nations and the Compulsory License: Maximizing Access to Essential Medicines While Minimizing Investment Side Effects
|
Bird, Robert C.
|
|
2009
|
37 |
2 |
p. 209-221
|
artikel
|
| 9 |
Differences in Regulatory Frameworks Governing Genetic Laboratories in Four Countries
|
Tassé, Anne Marie
|
|
2009
|
37 |
2 |
p. 351-357
|
artikel
|
| 10 |
Just a Spoonful of Sugar: Drug Safety for Pediatric Populations
|
Noah, Barbara A.
|
|
2009
|
37 |
2 |
p. 280-291
|
artikel
|
| 11 |
Pharmaceutical Innovation: Law & the Public's Health
|
Outterson, Kevin
|
|
2009
|
37 |
2 |
p. 173-175
|
artikel
|
| 12 |
Prizes and Parasites: Incentive Models for Addressing Chagas Disease
|
Crager, Sara E.
|
|
2009
|
37 |
2 |
p. 292-304
|
artikel
|
| 13 |
Pushing the Dead into the Next Reproductive Frontier: Post Mortem Gamete Retrieval under the Uniform Anatomical Gift Act
|
Spielman, Bethany
|
|
2009
|
37 |
2 |
p. 331-343
|
artikel
|
| 14 |
Recent Case Developments in Health Law
|
Hartman, Brett
|
|
2009
|
37 |
2 |
p. 380-388
|
artikel
|
| 15 |
Riegel v. Medtronic, Inc.: Revisiting Pre-Emption for Medical Devices
|
Patsner, Bruce
|
|
2009
|
37 |
2 |
p. 305-317
|
artikel
|
| 16 |
Right to Experimental Treatment: FDA New Drug Approval, Constitutional Rights, and the Public's Health
|
Leonard, Elizabeth Weeks
|
|
2009
|
37 |
2 |
p. 269-279
|
artikel
|
| 17 |
Teaching Health Law
|
Todres, Jonathan
|
|
2009
|
37 |
2 |
p. 375-379
|
artikel
|
| 18 |
The Pharmacist's Obligations to Patients: Dependent or Independent of the Physician's Obligations?
|
Altilio, Jason V.
|
|
2009
|
37 |
2 |
p. 358-368
|
artikel
|
| 19 |
Using Patent Data to Assess the Value of Pharmaceutical Innovation
|
Kesselheim, Aaron S.
|
|
2009
|
37 |
2 |
p. 176-183
|
artikel
|
| 20 |
When Scientists Deceive: Applying the Federal Regulations
|
O'Neil, Collin C.
|
|
2009
|
37 |
2 |
p. 344-350
|
artikel
|
| 21 |
Wild-Card Patent Extensions as a Means to Incentivize Research and Development of Antibiotics
|
Sonderholm, Jorn
|
|
2009
|
37 |
2 |
p. 240-246
|
artikel
|
Tijdschrift beschrijving